Startups
MIP Discovery

Developer of non-biological affinity reagents to accelerate the production of cell and gene therapies.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Seedtable Score

Score icon 37

Locations

Company Size

  • 11 to 50

Last Stage Round

Industry

Insights

Total Funding
$8.8M
Investors